Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|June 29, 2014
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individualsBianca Altvater, Sareetha Kailayangiri, Nadine Theimann, et al.
Oncotarget|February 22, 2018
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-GChristian Spurny, Sareetha Kailayangiri, Bianca Altvater, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2014
Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow?Andre M Willasch, Hermann Kreyenberg, Nona Shayegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
Cancers|December 11, 2022
Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing SarcomaCarolin Prexler, Marie Sophie Knape, Janina Erlewein-Schweizer, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
Molecular Therapy. Methods & Clinical Development|March 26, 2021
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cellsNicole Cordes, Carolin Kolbe, Dominik Lock, et al.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
BMC Cancer|September 11, 2019
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testingLena Andersch, Josefine Radke, Anika Klaus, et al.
Oncotarget|January 10, 2018
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cellsNicola Mitwasi, Anja Feldmann, Ralf Bergmann, et al.
Pageof 15